Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

AGX818 SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen

COVID-19 Spike Protein S1 (aa 1-681) Recombinant Antigen, expressed in HEK293 cells, Cat. No. AGX818 is tested for use in ELISA, Lateral Flow Assay as Positive Control.

AGX818
100 μg  
Purchase on Sigma-Aldrich

Overview

Replacement Information
Description
Catalogue NumberAGX818
DescriptionSARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen
Alternate Names
  • COVID-19
  • 2019-nCoV
Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 spike antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
References
Product Information
FormatPurified
PresentationPurified in 10mM Phosphate Buffered Saline with 0.09% sodium azide, pH 7.0.
Quality LevelMQ100
Applications
ApplicationCOVID-19 Spike Protein S1 (aa 1-681) Recombinant Antigen, expressed in HEK293 cells, Cat. No. AGX818 is tested for use in ELISA, Lateral Flow Assay as Positive Control.
Key Applications
  • Positive Control
  • ELISA
  • Immunodiffusion
Biological Information
ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
HostHuman Recombinant
Purification MethodAffinity Chromatography
UniProt Number
Molecular Weight76 kDa
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size100 μg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
AGX818 04061842605927

Documentation

SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen SDS

Title

Safety Data Sheet (SDS) 

SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen Certificates of Analysis

TitleLot Number
SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3596269 3596269
SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3666807 3666807
SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3674836 3674836
SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3683143 3683143
SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3693112 3693112
SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3706646 3706646
SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3709543 3709543
SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3723429 3723429
SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3756564 3756564
SARS-CoV-2 Spike Protein S1 (aa 1-681) Recombinant Antigen - 3757092 3757092
Show more